Semaglutide tablet (Rybelsus), the first GLP-1RA developed for oral administration, heralds a milestone for diabetes management in the 15 years since the introduction of the first glucagon-like peptide-1 receptor agonist (GLP-1RA). Rybelsus and its parenteral counterpart, Semaglutide (Ozempic), are approved for use in the treatment of . . .
Sign Up or Log In as a healthcare professional to read the full article.
Pancreatic cancer is the 12th most commonly found cancer globally, affecting men more than women.
Sandra Bullock’s partner, Bryan Randall, succumbs to ALS at 57, drawing attention to the devastating
Hong Kong is experiencing an alarming increase in obesity as a result of its residents’
Read this article to learn more about the seven symptoms that signify an immediate visit to a gastroenterologist
Canadian superstar Celine Dion’s diagnosis with Stiff Person Syndrome has turned the world’s attention to this rare neurological disorder.
Osteopenia is a condition where there is low bone mass, indicating weaker bones more prone to breakage, but not as severe as osteoporosis. Bone mass
